||Medable Launches TeleConsent for Clinical Trials, Dramatically Improving Patient Access and Experience | Business Wire
||PALO ALTO, Calif.- Medable Inc. , the leading software provider for decentralized clinical trials, today announced general availability of Medable TeleConsent™, a new product that enables fully remote informed consent and re-consent for clinical trials ... study participants without meeting in person, taking advantage of Medable’s TeleVisit application to conduct personalized interactions that improve patient understanding. Sites and sponsors benefit from streamlined workflows and enhanced data quality and compliance. Sponsors also ...
||Medable Achieves 400% Growth in First Half 2020, Expands Ecosystem for Decentralized Clinical Trials | Business Wire
||PALO ALTO, Calif.--( BUSINESS WIRE )-- Medable Inc. , the leading software provider for decentralized clinical trials, today announced strong momentum in the first half of 2020 as pharma and biotech companies quickly shifted clinical trials to ... additional investment from existing investor PPD, Inc. Launched a mobile TeleVisit application , co-developed and deployed with PPD, to enable continued clinical research in light of COVID-19 concerns. TeleVisit connects patients virtually with site ...
||Medable Releases Global TeleVisit Capabilities to Enable Continued Clinical Trial Research in Light of Growing COVID-19 Concerns | Business Wire
||PALO ALTO, Calif.- In response to the global COVID-19 pandemic, Medable has developed a new TeleVisit mobile application that can be used by patients worldwide to connect virtually with their clinical trial sites. The application makes it possible for clinical trial research to progress in an environment where many patients are being told to stay home and avoid social interaction. The application includes the following capabilities: Consents patients in ...